News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BaroFold, Inc. Awarded Patent For Using High Pressure To Improve The Safety Profile Of Biologic Drugs


4/23/2014 9:48:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AURORA, Colo.--(BUSINESS WIRE)--BaroFold, Inc. today announced it was awarded U.S. Patent No. 8,697,848, entitled “Method for reducing immunogenicity of therapeutic protein compositions,” which provides additional protections over the company’s Pressure Enabled Protein Manufacturing Technology (PreEMT™). PreEMT is being used by BaroFold’s industry partners to improve the tolerability, efficacy and safety of a wide variety of protein therapeutics.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES